Wearable Blood Pressure Monitor Versus Upper Arm Cuff in People With Hypertension
Compares a wearable blood pressure monitor with a standard arm cuff in hypertension.
Plain-language title generated from the registry record
Registry title: WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control
Key facts
- Where
- Boston, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 85 years old?
Source: NCT07523269, who can take part
Where in United States
- Mass General Brigham HospitalBoston, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Aktiia SA
- Trial code
- NCT07523269
- Record updated
- 13 April 2026
- Original description
The WEARABLE-BP study will evaluate the clinical value of obtaining continual measurements using the Aktiia G1 Optical Blood Pressure Monitoring (OBPM) device in hypertensive patients, compared to using a traditional upper arm cuff for home BP monitoring.Read full original descriptionShow less
WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control
The WEARABLE-BP study will evaluate the clinical value of obtaining continual measurements using the Aktiia G1 Optical Blood Pressure Monitoring (OBPM) device in hypertensive patients, compared to using a traditional upper arm cuff for home BP monitoring.
The WEARABLE-BP study aims to compare the change in unattended automated office blood pressure from baseline to 6 months between two study groups: those given an Aktiia G1 BP monitor and those given a traditional upper arm BP cuff.
Inclusion: Adults aged 21 to 85 years; Able to read and speak English; Have an MGB provider and medical record number in EPIC; Study participants will wear the Aktiia bracelet for 6 months; Willing to attend two on-site study visits and comply with all study procedures; Signed informed consent provided; Own a smartphone with iOS or Android operating system; Hypertensive with uncontrolled systolic blood pressure (SBP) >135 mm Hg by unattended automated office measurement; Currently taking 0, 1 or 2 antihypertensive medications.
Exclusion: Severe hypertension (SBP > 180 mmHg or DBP > 120 mmHg); Known severe valvular heart disease; Known resting heart rate > 120 bpm; Known Raynaud's disease; Known tremors or shivering disorders; Known exfoliative skin diseases; Known allergy to silicone; Presence of implanted devices, such as a pacemaker, defibrillator, intravascular device, or arteriovenous fistula; Known severe heart failure (LVEF < 35%); Known severe chronic kidney disease (CKD stage 4-5; eGFR < 30 mL/min/1.73 m²); Known severe diabetes (Hemoglobin A1c > 10%); Pregnant or breastfeeding; Known pheochromocytoma; Known uncontrolled hyperthyroidism or hypothyroidism; Known persistent atrial fibrillation; Presence of lymphedema; Paralysis of the arm; Arm amputation; Upper arm circumference < 22 cm or > 42 cm; Wrist circumference > 23 cm; Mastectomy.